Table 2.
Correlation of GAS5 and miR-155 expression with clinicopathologic parameters in 62 Pneumonia patients
| Pneumonia (n = 62) | GAS5 expression level | P value | miR-155 expression level | P value | |||
|---|---|---|---|---|---|---|---|
| Low | High | Low | High | ||||
| Years | |||||||
| ≤ 2 | 30 | 14 | 16 | P > 0.05 | 18 | 12 | P > 0.05 |
| > 2 | 32 | 17 | 15 | P > 0.05 | 16 | 16 | P > 0.05 |
| Gender | |||||||
| Male | 37 | 16 | 21 | P > 0.05 | 19 | 18 | P > 0.05 |
| Female | 25 | 13 | 12 | P > 0.05 | 10 | 15 | P > 0.05 |
| Infection | |||||||
| Viral | 34 | 16 | 18 | P > 0.05 | 17 | 17 | P > 0.05 |
| Bacterial | 28 | 15 | 13 | P > 0.05 | 12 | 16 | P > 0.05 |
| PSI | |||||||
| I–III | 16 | 4 | 12 | P < 0.05** | 11 | 5 | P < 0.05** |
| IV | 28 | 18 | 10 | P < 0.01** | 8 | 20 | P < 0.01** |
| V | 18 | 16 | 2 | P < 0.01** | 1 | 17 | P < 0.01** |
Pneumonia severity index (PSI), *P < 0.05, **P < 0.01